Navigation Links
'Snapshots' of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
Date:7/14/2008

llogg scientists found that FA activity was significantly higher for those with diabetes, regardless of severity, compared to those who did not have the disease. The results were not affected by disease severity or duration and were elevated for diabetics in each age group: 30 to 39 years, 40 to 49 years, and 50 to 59 years.

Given the increasing prevalence of diabetes, the FA device holds the potential to help address a leading and growing public health concern.

Some 24 million Americans have diabetes and an additional 57 million individuals have abnormal blood sugar levels that qualify as pre-diabetes, according to the latest report from the Centers for Disease Control and Prevention. In addition, 4.1 million people over the age of 40 suffer from diabetic retinopathy, an eye-related complication of diabetes that is the leading cause of blindness among working-age adults.

Twelve individuals in the study were known to have diabetic retinopathy, a disease in which blood vessels in the eye are damaged. The individuals with diabetic retinopathy in at least one eye had significantly greater FA activity than people with diabetes who do not have any visible eye disease.

"The abnormal readings indicated that it may be possible to use this method to monitor the severity of the disease," says Elner.

Petty, a biophysicist and imaging expert, explains that hyperglycemia -- or high blood sugar -- is known to induce cell death in diabetic tissue soon after the onset of disease but before symptoms can be detected clinically.

"Increased FA activity is the earliest indicator that cell death has occurred and tissue is beginning to break down," says Petty, professor of Ophthalmology and Visual Sciences, and professor of Microbiology and Immunology at the U-M Medical School. "FA serves as a 'spectral-biomarker' for metabolism gone awry, and we can use the results to detect and monitor disease."

Petty also observes that unlike glucose mon
'/>"/>

SOURCE University of Michigan Health System
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children
2. Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors Visits
3. Drug Combo Could Lower Diabetes Complications and Costs
4. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
5. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
6. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
7. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
8. St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases
9. Mayo Clinic Study Shows Drug Could Effectively Treat, Prevent the Spread of Breast Cancer
10. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
11. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...ICK, Md., Jan. 7 ImQuest Life Scie...an IND application to the Food and Drug Administra...ead pyrimidinedione HIV inhibitor IQP-0410. ImQues...the first quarter of 2009. IQP-0410 is a novel sma...as a nonnucleoside reverse transcriptase inhibitor...
(Date:1/6/2009)...m Expands on Successful Results from prior U.S., U...ewswire/ -- Vital Therapies, Inc. (VTI), a develop...announced patient enrollment has begun for a rando...trial that will study the Extracorporeal Liver Ass... Acute Liver Failure (ALF) under three protocols. ...
(Date:1/6/2009)...LLE, Md., Jan. 6 Sequel...ny focused on diseases of epidemic potential, anno...r the treatment of tuberculosis (TB), was the firs...clinical program contract to Dynport Vaccine Compa...awarded by the National Institute of Allergy and I...
(Date:1/5/2009)...EGO, Jan. 5 Cylene Pharmaceuticals...linical trial of its oral CK2 protein kinase inhib...ors, Castleman,s disease, or multiple myeloma. The...al are determination of safety, tolerance and PK p... dose for Phase II trials. In addition, multiple m...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3The sea ice is getting thinner 372 1The sea ice is getting thinner 372 2The sea ice is getting thinner 372 3The sea ice is getting thinner 372 4Nucletron Announces Management Buy Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community 1185 1Nucletron Announces Management Buy Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community 1185 2Nucletron Announces Management Buy Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community 1185 3MDMA Names New Director of Federal Affairs 1180 1MDMA Names New Director of Federal Affairs 1180 2Metabolic syndrome heightens risk for development of uric acid kidney stones 1179 1Metabolic syndrome heightens risk for development of uric acid kidney stones 1179 2
...agonist shown to be therapeutically effective in a...PENHAGEN, 18 April 2007 - Santaris Pharma, the Dan...s, yesterday,presented encouraging data at the Ame...ng in Los Angeles, showing that SPC2996, the,Compa...ctive in a,preclinical model of human Chronic Lymp...
...Calif., April 18, 2007 /PRNewswire-FirstCall/ -- K...linical data on its,proprietary nuclear export inh...ting and long-lasting anticancer activity with a,h... xenograft,cancer models. , Kosan,s NEIs are poten..., essential protein that exports key regulatory pr...
Other Medicine Technology:Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 2Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 3Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 4Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 5Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 6Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 2Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 3Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 4
(Date:1/8/2009)...e Promoted to Principal. Christine Siu and Jason ...NEAPOLIS, SAN FRANCISCO and STAMFORD, Conn., Jan. ... a health care venture capital firm that invests i...oday announced the promotion of three members of i...to Principal. Christine Siu and Jason Brown have ...
(Date:1/8/2009)...tically-navigated guidewire provides minimally-inv..., AUSTIN, Texas, Jan. 8 The Hear... world to use the new Stereotaxis RF PowerAssert(T...c total occlusions (CTOs), or complete blockages i...Austin Heart interventional cardiologist, Frank Zi...
(Date:1/8/2009)...n University and Baxter Healthcare Corporation wil...on alliance, the two entities announced today. , ...will fund research-collaboration projects at North...proximately $1 million, and Baxter will determine ...basis. Aligned with Baxter,s diversified business ...
(Date:1/8/2009)...a., Jan. 8 The National eHealth Co...announced the results of its organizational leader...t and CEO of Prematics, Inc., was elected to serve... Directors. The Collaborative builds on the accom...unity (AHIC), a federal advisory committee establi...
Breaking Medicine News(10 mins):Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2Health News:Heart Hospital of Austin First in World to Use New Device for Blocked Arteries 2Health News:Baxter and Northwestern University partner to target new life sciences projects 2Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2
...he Washington University School of Medicine in St....ck the butt by revealing that smoking interferes ... study on a mouse model and found that cigarette s...ls to the injury site and delays healing following...
... ramp for nearly 20 years, it seems that time is t...ed at Sir Paul McCartney's 65th birthday party in ...legs. The dress, a cream Old Hollywood-style garme...' favorite, since it was worn by her on her own bi...
...s well as tourists are heading for the nearest bee... a chilled glass of beer . This is evident from t...e packed with guzzlers. Over ninety percent of the...eer with a mere ten percent opting for hard liquor...
...dy found that younger menopausal women (aged 50-59...estrogens had significantly less coronary artery c...red with those taking placebo. Coronary artery cal...e arteries and a predictor of future cardiovascula...
Other Medicine News:Health News:Smoking Hampers Healing of the Ligament 2Health News:Women Taking Oestrogen Therapy Showed Reduced Coronary Artery Calcification 2
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products: